Connective tissue growth factor (CTGF) methylation status is associated with prognosis of patients with head and neck squamous cell carcinoma (HNSCC) treated with radiochemotherapy (RCHT): A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Bouchra Tawk,Christian Schwager,Karim Zaoui,Jochen Hess,A. Linge,Volker Budach,Martin Stuschke,Panagiotis Balermpas,Anca L. Grosu,Daniel Zips,Stephanie E. Combs,Mechthild Krause,Elias Kouchakji,Kenneth E. Lipson,Esther Herpel,Claus Belka,Michael Baumann,Christel Herold-Mende,Juergen Debus,Amir Abdollahi

Connective tissue growth factor (CTGF) methylation status is associated with prognosis of patients with head and neck squamous cell carcinoma (HNSCC) treated with radiochemotherapy (RCHT): A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

2019

6050Background: CTGFplays a central role in tissue remodelingand has emerged as an attractive novel therapeutic target. We sought to investigate the impact of CTGFmethylation status ( CTGF-M) in ...

Keywords:

CTGF
Cancer
Head and neck squamous-cell carcinoma
Growth factor
Methylation
Internal medicine
Oncology
Connective tissue
Medicine
radiation oncology
multicenter study
Pathology

Correction
Source
Cite
Save

References

Citations